Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Nurx Delivers PCR-Quality Rapid Home Test for COVID-19

Building on a year of record growth, the leading female-focused digital health platform is among the first distributors of the Lucira Check It COVID-19 Test Kit, a direct-to-consumer PCR quality molecular test that empowers users to get reliable results from home in 30 minutes or less.


News provided by

Nurx

Apr 26, 2021, 07:00 ET

Share this article

Share toX

Share this article

Share toX


SAN FRANCISCO, April 26, 2021 /PRNewswire-PRWeb/ -- Nurx, the leading telehealth platform providing specialized care for female-focused health needs, today announced it is among the first authorized distributors of the Lucira Check It COVID-19 Test Kit, the first and only single-use PCR-quality test offered directly to consumers intended to detect the novel coronavirus SARS-COV-2 that causes COVID-19. The Lucira Check It test provides PCR-quality molecular accuracy results in 30 minutes. The Lucira test also comes with a free verified results digital LUCI PASS that consumers can easily access by using their phone to scan their test results into the company's secure LUCI portal.

"Even as vaccination becomes widespread, we expect that COVID-19 infection will continue to be a concern and we are excited to offer people a reliable way to detect or rule out infection from the safety and convenience of their homes," says Jennifer Peña, MD, Chief Medical Officer at Nurx. "Testing will likely be a part of life for a while, and patients will need a variety of options for testing, depending on their situation."

...As the pandemic enters this next phase we are excited to offer the Lucira Check It COVID-19 Test Kit to give people another option for detecting COVID-19 infection, so they can keep themselves and others safe.

Post this

In a recent survey of more than 1,000 Nurx patients, a majority said they are eager to begin dating and socializing again once they're vaccinated and/or pandemic restrictions are lifted, but 25% said they will continue to be worried about catching COVID-19; 63% said they are definitely or possibly interested in fast and reliable at-home testing through Nurx.

Because the Lucira Check It COVID-19 Test Kit is available without a prescription and can be kept on hand for up to six months, Nurx anticipates it will fill an important need for people who want fast, reliable COVID-19 testing at their fingertips to rule out infection as they resume socializing and travel, or to confirm that they are COVID-19 negative before an in-person gathering or travel.

  • COVID-19 test builds upon Nurx's home testing success and provides a valuable option for both individuals and businesses.

Home testing for COVID-19 is the latest home test and diagnostic offered by Nurx, which provides testing for sexually transmitted infections, cervical cancer screening and the tests needed to start and stay on PrEP for HIV prevention. Since the start of the pandemic, Nurx has seen demand for its existing home tests more than double.

In anticipation of demand from employers and businesses looking to bring people safely back to the office or to in-person events, Nurx will make the Lucira Check It COVID-19 Test Kit available for bulk order by businesses who need to test large groups of people at once.

"We hear from both patients and employers that they want the ability to access highly accurate COVID-19 tests quickly and conveniently, " says Varsha Rao, CEO of Nurx. "As the pandemic enters this next phase we are excited to offer the Lucira Check It COVID-19 Test Kit to give people another option for detecting COVID-19 infection, so they can keep themselves and others safe."

  • Lucira Check It COVID-19 Test Kit is the only PCR-quality single-use home test available direct to consumers.

The Lucira Check It COVID-19 Test Kit recently received FDA Emergency Use Authorization (EUA) for over-the-counter (OTC) use. (1) The test kit will be used by the Golden State Warriors to test their in-person spectators this NBA season. Ticket holders who have not yet been vaccinated will be sent a Lucira Check It kit and required to test within 48 hours of the game and show their negative test results before entering Chase Center.

The Lucira test is a single-use, molecular in vitro diagnostic test with analytical sensitivity comparable to one of the best known high-sensitivity lab PCR tests. Other rapid home COVID tests are antigen tests.

The Lucira Check It COVID-19 Test Kit includes everything the patient needs to receive a PCR-quality molecular result in 30 minutes: a nasal swab, a vial filled with fluid for sample analysis and a battery-operated test unit. The patient swabs both nostrils, swirls the swab in the fluid included in the vial, and then seals the vial and presses it into the test unit. Within a half an hour, the test unit displays a light clearly indicating whether the patient has tested positive or negative for COVID-19. Then the patient uses a smartphone to text into the LUCI portal to obtain a verified digital result LUCI PASS.

Purchased individually, a Lucira Check It COVID-19 Test Kit costs $65, which includes free ground shipping (expedited shipping is available at an additional cost). Bulk pricing is available for large orders. Tests can be purchased from Nurx by those 14 and older in all 50 states.

"We are excited about our Nurx partnership. We know that for many this past year has been a time of high uncertainty and we are all missing closer contact with loved ones and friends. Providing a test like Lucira Check It allows people to check themselves so they can begin socializing with others with greater certainty and peace of mind. Nurx's dedication to providing home tests that provide greater peace of mind like Lucira reflects a responsiveness and commitment to its members," says Erik Engelson, Lucira's CEO.

Nurx has experienced unprecedented growth over the past year, registering more than 500,000 new consultations with providers, which brings its total lifetime number to more than 1.1M. Touchpoints with patients grew to 7.25M, with 3.15M taking place in 2020 alone. Nurx is focused on offering high-quality healthcare for needs which can be difficult to access and often carry shame and stigma. Today, Nurx offers healthcare services from contraception, to dermatology for acne and anti-aging, headache and migraine treatment, herpes, PrEP for HIV prevention, testing for STIs and HPV and now at-home testing for COVID-19.

The Lucira Check It COVID-19 Test Kit will be available in all 50 states. To learn more, visit https://www.nurx.com/covid-test. Employers or organizations interested in bulk orders should contact [email protected].

About Nurx
Nurx is a health tech company providing convenient, affordable, and personalized care for sensitive health needs. By reimagining the healthcare experience, Nurx offers patients transparent pricing and judgment-free care whenever and wherever works best for them. We believe everyone should have the freedom to live well and be in charge of their healthcare decisions, regardless of their circumstances. From diagnosis to delivery, we make every part of getting healthy and staying healthy, better.

About Lucira Health
Lucira is a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits. Lucira's testing platform produces lab quality molecular testing in a single-use, consumer-friendly, palm size test kit powered by two AA batteries. Lucira designed its test kits to provide accurate, reliable and on-the-spot molecular test results anywhere and at any time. The LUCIRA CHECK IT (OTC) and LUCIRA COVID19 All-In-One Test Kit (RX) are designed to provide a clinically relevant COVID-19 result within 30 minutes from sample collection.

(1) https://www.nurx.com/covid-test/ - The Lucira Check It COVID-19 Test Kit has not been FDA cleared or approved, The Lucira Check It COVID-19 Test Kit has been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens.

Media Contact

Ann Noder, Pitch Public Relations, +1 480.263.1557, [email protected]

SOURCE Nurx

Related Links

https://www.nurx.com/

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.